Sargent Investment Group, LLC Bluebird Bio, Inc. Transaction History
Sargent Investment Group, LLC
- $546 Million
- Q3 2024
A detailed history of Sargent Investment Group, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Sargent Investment Group, LLC holds 38,515 shares of BLUE stock, worth $12,324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,515
Previous 38,515
-0.0%
Holding current value
$12,324
Previous $37,000
45.95%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BLUE
# of Institutions
152Shares Held
63.7MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$4.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$3.35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$1.5 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$1.49 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$1.23 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $24.7M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...